iBio - Die Impfstoffmaschine (Seite 1776)
eröffnet am 16.03.11 21:21:25 von
neuester Beitrag 02.05.24 21:50:27 von
neuester Beitrag 02.05.24 21:50:27 von
Beiträge: 18.250
ID: 1.164.726
ID: 1.164.726
Aufrufe heute: 2
Gesamt: 2.207.205
Gesamt: 2.207.205
Aktive User: 0
ISIN: US4510337086 · WKN: A3E2GR · Symbol: IBIO
1,9900
USD
0,00 %
0,0000 USD
Letzter Kurs 02:04:00 NYSE Arca
Neuigkeiten
Werte aus der Branche Biotechnologie
| Wertpapier | Kurs | Perf. % |
|---|---|---|
| 6.300,00 | +4.940,00 | |
| 1,4600 | +34,94 | |
| 1,2300 | +24,24 | |
| 2,7600 | +20,00 | |
| 0,8000 | +19,40 |
| Wertpapier | Kurs | Perf. % |
|---|---|---|
| 21,600 | -20,00 | |
| 1,3800 | -20,80 | |
| 0,6700 | -26,58 | |
| 2,1300 | -34,41 | |
| 3,1600 | -38,64 |
Beitrag zu dieser Diskussion schreiben
Feedback
Antwort auf Beitrag Nr.: 48.065.809 von Jagubert am 17.10.14 13:04:01Selber gefunden.
http://ibioinc.com/ibio-responds-to-inquiries-about-its-role…
http://ibioinc.com/ibio-responds-to-inquiries-about-its-role…
Antwort auf Beitrag Nr.: 48.065.788 von ikarusfly am 17.10.14 13:01:57Kannst Du bitte die Quelle nennen?
IBIO announced that in collaboration with Caliber Biotherapeutics, it will help the in the government effort to ramp up production of Ebola-related drugs. iBio uses the iBioLaunch platform, which is a proprietary gene expression technology capable of producing high levels of target proteins in plants. Ultimately these proteins are used to create vaccines and can be produced quickly and efficiently. Using this technology iBio can bring its Ebola treatment to market quicker than expected Less 
Trading Spotlight
@ gerdass, Du hast doch nicht etwa verkauft, oder?
06:47 $ 2.24 High Pre-Market 
Mir reichen meine 58%.
Antwort auf Beitrag Nr.: 48.065.446 von gerdass am 17.10.14 12:37:22Glaub ich eher nicht, da im After Hours 1.312.643 Aktien zu Kursen von bis
zu 2,38$ gehandelt wurden. Denke eher, hier müssen heute noch einige Kaufen
und ihre Positionen glatt stellen. Wir werden sehen wer Recht hat.
zu 2,38$ gehandelt wurden. Denke eher, hier müssen heute noch einige Kaufen
und ihre Positionen glatt stellen. Wir werden sehen wer Recht hat.
Hmmm.....
"IBIO Valuation, share price $40 to $140 per share, market cap 4 to 15 bln
here is back of envelope IBIO valuation
From IBIO website, they are working with partners on products with estimated sale 22 bln
assuming 5%- 10% royalties (licencing fee plus sales milestones), then IBIO cut is 1-2bln,
as this is royalties, most of them would be profit, hence assuming PE= 20 valuation is 20-40 bln
assuming some dilution, taking share number as 100 mln,
would result in Share price $200-$400
Now those products would take 3-5 years to develop, assuming discounted rate 40%
the valuation would be minimum= 200/1.4/1.4/1.4/1.4/1.4/1.4 ~$40
maximum 400/1.4/1.4/1.4=$145
Current price $1.5
Make no mistake, from now on every big phama will be switching to IBIO technology, because
1) its 50% cheaper
2) its much faster,
Down side, take over at cheap price, much less than $40"
via http://finance.yahoo.com/mbview/threadview/;_ylt=AmWl6WFukPD…
"IBIO Valuation, share price $40 to $140 per share, market cap 4 to 15 bln
here is back of envelope IBIO valuation
From IBIO website, they are working with partners on products with estimated sale 22 bln
assuming 5%- 10% royalties (licencing fee plus sales milestones), then IBIO cut is 1-2bln,
as this is royalties, most of them would be profit, hence assuming PE= 20 valuation is 20-40 bln
assuming some dilution, taking share number as 100 mln,
would result in Share price $200-$400
Now those products would take 3-5 years to develop, assuming discounted rate 40%
the valuation would be minimum= 200/1.4/1.4/1.4/1.4/1.4/1.4 ~$40
maximum 400/1.4/1.4/1.4=$145
Current price $1.5
Make no mistake, from now on every big phama will be switching to IBIO technology, because
1) its 50% cheaper
2) its much faster,
Down side, take over at cheap price, much less than $40"
via http://finance.yahoo.com/mbview/threadview/;_ylt=AmWl6WFukPD…
Durchsuchen
